Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4745567 | PMC |
| http://dx.doi.org/10.1038/srep20462 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Corrigendum to "Cross talk between the liver microbiome and epigenome in patients with metabolic dysfunction-associated steatotic liver disease".
EBioMedicine
January 2025
Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina; Faculty of Health Science, Maimónides University, Buenos Aires, Argentina; Clinical and Molecular Hepatology, Translational Health Research Center (CENITRES), Maimónides University, Buenos Aires, Argentina. Electronic address:
Corrigendum "Enhancement of gemcitabine efficacy by K73-03 via epigenetically regulation of miR-421/SPINK1 in gemcitabine resistant pancreatic cancer cells" [Phytomedicine 2021:91:153711].
Phytomedicine
January 2025
Acad integrated Med & Collage of Pharmacy, School of Pharmacy, Dalian Medical University, Dalian, China. Electronic address:
Corrigendum to "Dimerization of ZIP promotes its transcriptional repressive function and biological activity" [Int. J. Biochem. Cell Biol. 44 (2012) 886-895].
Int J Biochem Cell Biol
December 2024
Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Biochemistry and Molecular Biology, Peking University Health Science Center, Beijing 100191, China; Tianjin Key Laboratory of Medical Epigenetics, Department of Biochemistry and Molecular Biology, Tianjin Medical University, Tianjin 300070, China. Electronic address:
Corrigendum: Advances in understanding the regulation of pluripotency fate transition in embryonic stem cells.
Front Cell Dev Biol
November 2024
Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.
[This corrects the article DOI: 10.3389/fcell.2024.
View Article and Find Full Text PDFCorrigendum: A disintegrin and metalloproteinase domain 10 expression inhibition by the small molecules adenosine, cordycepin and N6, N6-dimethyladenosine and immune regulation in malignant cancers.
Front Immunol
November 2024
Key Laboratory of Epigenetics and Oncology, The Research Center for Preclinical Medicine, Southwest Medical University, Luzhou, Sichuan, China.
[This corrects the article DOI: 10.3389/fimmu.2024.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!